Registry

Type of Study

Data are collected on an annual basis.

Data gathering method

Registries

Registry

Type of Study

Data are collected on an annual basis.

Data gathering method

Registries

Conditions of access

The research plan must be approved by SII before the data can be used. Linkages to other registries require separate applications for permission.

Register data

Conditions of access

The research plan must be approved by SII before the data can be used. Linkages to other registries require separate applications for permission.

Register data

Data are collected annually.

The dataset provides data on: • Reimbursements for medical and pharmaceutical expenses • Sickness and disability allowances • Occupational health care • Rehabilitation allowances

Data are collected annually.

The dataset provides data on: ·         Reimbursements for medical and pharmaceutical expenses ·         Sickness and disability allowances ·         Occupational health care ·         Rehabilitation allowances

Linkages to other registries require separate applications for permission, possible to link using the unique personal identification number.

Linkages to other registries require separate applications for permission, possible to link using the unique personal identification number.

Strengths: KELA database is the major source of information on the consumption of pharmaceuticals. Volumes and types of (reimbursed) drug purchases can be used to approximate the use of various types of drugs. In addition, drug consumption information can be used to supplement the often incomplete comorbidity information in the national discharge register (especially in the case of chronic diseases, e.g. diabetes). Weaknesses: aggregated data; but individual level data can be obtained for research purposes.

Strengths: KELA database is the major source of information on the consumption of pharmaceuticals. Volumes and types of (reimbursed) drug purchases can be used to approximate the use of various types of drugs. In addition, drug consumption information can be used to supplement the often incomplete comorbidity information in the national discharge register (especially in the case of chronic diseases, e.g. diabetes). Weaknesses: aggregated data; but individual level data can be obtained for research purposes.